Revisiting the Elusive Hepatitis C Vaccine
The impactful discovery and subsequent characterisation of hepatitis C virus (HCV), an RNA virus of the flavivirus family, led to the awarding of the 2020 Nobel Prize in Physiology or Medicine to Harvey J. Alter, Michael Houghton and Charles M. Rice [...]
Main Authors: | Stephen M. Todryk, Margaret F. Bassendine, Simon H. Bridge |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/2/114 |
Similar Items
-
Relapse of polymyalgia rheumatica following adjuvanted influenza vaccine: A case-based review
by: Margaret F. Bassendine, et al.
Published: (2020-01-01) -
Modified Alphavirus-Vesiculovirus Hybrid Vaccine Vectors for Homologous Prime-Boost Immunotherapy of Chronic Hepatitis B
by: Carolina Chiale, et al.
Published: (2020-06-01) -
The Challenging Road to Hepatitis C Virus Eradication
by: Isidoro Martínez, et al.
Published: (2021-02-01) -
Hepatitis B and C Viruses and Hepatocellular Carcinoma
by: Birke Bartosch
Published: (2010-07-01) -
Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma
by: Thomas F. Baumert, et al.
Published: (2019-05-01)